Q3 FY2026 · ended Jun 30, 2026 · Revenue $50,700, -52.4% YoY · Filed Aug 14, 2026
Global Innovative Platforms Inc. (GIPL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $50,700 and a net loss of $241,611. Free cash flow was -$188,681. As of Jun 30, 2026 it held $244,235 in cash and investments and $5,616 in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- GIPL (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Maitland, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837774
- Former names
- Canning Street Corp (until Sep 10, 2021)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $50,700 | $106,500 | $30,000 | — | — |
| Operating income | -$241,611 | -$151,386 | -$49,429 | -$234,616 | -$211,818 |
| Net income | -$241,611 | -$151,386 | -$49,429 | -$234,616 | -$211,818 |
| Diluted EPS | — | — | -$0.00 | -$0.00 | -$0.01 |
| Operating cash flow | -$133,565 | -$149,473 | $12,676 | -$64,861 | -$184,273 |
| Free cash flow | -$188,681 | -$217,588 | — | — | — |
| Total assets | $539,261 | $591,958 | $224,951 | $199,275 | $209,160 |
| Total liabilities | $7,791 | $2,284 | $65,784 | $11,609 | $27,823 |
| Stockholders' equity | $531,470 | $589,674 | $159,567 | $187,666 | $181,337 |
| Cash and investments | $244,235 | $327,270 | — | — | — |
| Total debt | $5,616 | $0 | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Oct 6, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 15, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Officer or director change
|
May 20, 2026 | May 20, 2026 |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
All 97 Global Innovative Platforms Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.